The cost of immunotherapy in India can vary depending on the type of treatment and the severity of the cancer. However, immunotherapy is generally more affordable than other types of cancer treatment, such as chemotherapy and radiation therapy. The average cost of immunotherapy in India is around Rs. 1,50,000- 4,50,000.
Dr. Saphalta is one of the leading cancer treatment centers in India, offering the latest treatments and technologies for cancer patients. Contact us today to learn more about our affordable immunotherapy services.
However, the costs can differ depending on various factors that play a major role in deciding the immunotherapy cost in India.
In India, immunotherapy is highly affordable and economical.
The cost mainly depends on the drugs used for the treatment, duration of the treatment, pre-treatment tests, expertise of the oncologist providing the treatment, and the medications to manage the side effects or other health concerns of the patient. Among these, the type of drug used, which depends on the type of cancer and the method of immunotherapy opted for, is the main determiner of the cost.
Dr. Saphalta Baghmar provides cost-effective immunotherapy treatment in India. With her specialization in this treatment, she ensures that her patients get the appropriate treatment needed for their efficient recovery.
Dr. Saphalta Baghmar, the best oncologist in India offers the latest treatments and technologies for cancer patients. Contact us today to learn more about our affordable immunotherapy services.
Immunotherapy costs in India can vary depending on factors such as the type of treatment, the severity of the cancer, and the medications used. However, it is generally more affordable than other cancer treatments like chemotherapy and radiation therapy. On average, immunotherapy cost in India ranges from Rs. 1,50,000 to 4,50,000.
Several factors influence the overall cost, including the drugs used, the duration of the treatment, pre-treatment tests, and the oncologist's expertise. The primary factor determining the cost is the type of drug, which depends on the type of cancer and the chosen immunotherapy method.
Dr. Saphalta Baghmar, the best oncologist in Faridabad, offers advanced and cost-effective immunotherapy treatments, ensuring her patients receive personalized care for their recovery. With her vast expertise, she utilizes the latest technologies and approaches in cancer care. For a more accurate cost range, talk with Dr. Saphalta Baghmar today.
Type of Immunotherapy |
Cost Range (INR) |
Comments |
Checkpoint Inhibitors |
2500- 1 .5 lacs |
Per cycle; commonly used for cancers like melanoma. |
CAR T-Cell Therapy |
₹30,00,000 - ₹60,00,000 |
Cost varies based on the type of cancer. |
Monoclonal Antibodies |
₹1,50,000 - ₹4,00,000 |
Per cycle; used in various cancers. |
Cancer Vaccines |
₹50,000 - ₹2,00,000 |
Depends on the type of vaccine. |
Adoptive Cell Transfer |
₹3,00,000 - ₹7,00,000 |
Personalized treatment costs can vary. |
Cytokines |
₹50,000 - ₹2,00,000 |
Costs per dose; varies by cancer type. |
Immunomodulators |
₹1,00,000 - ₹3,00,000 |
Often used in combination with other therapies. |
Targeted Antibodies |
₹1,50,000 - ₹5,00,000 |
Cost depends on the specific target and cancer type. |
Related Blog Immunotherapy vs Chemotherapy: Which Treatment is Better?
Before we discuss the actual immunotherapy cost, let's first look at all pre-treatment expenses.
Note: The number of sessions required will depend on the severity of the cancer. Some patients may require only one session, while others may require multiple sessions.
How does immunotherapy enhance the ability of your immune system? It does so by one of these five means.
This method introduces a group of antibodies to your body that specifically binds to the cancerous cells and alerts your immune system.
Also called T-cell transfer therapy, this method enhances the performance of your body's T-cells.
This method blocks the immunity checkpoints that prevent your body from eliciting a strong immune response.
These work similarly to normal vaccines and enhance your body's immune response.
These drugs work on certain aspects of your immune system, allowing for an overall strong immune response.
Any complex cancer treatment, including immunotherapy, requires the expertise of a specialized cancer department.
Related BlogNutrition And Cancer: How A Healthy Diet Can Support Different Stages Of Cancer
In India, immunotherapy is given to patients with advanced bladder cancer who are ineligible for cisplatin chemotherapy as a first-line treatment. Immunotherapy improves bladder cancer outcomes and reduces recurrence risk. Furthermore, it improves the patient's survival rate. As the first approved immunotherapy, BCG stimulates the immune system, which targets bacteria and bladder cancer cells nearby.
Dr. Saphalta Baghmar and her team provide customized breast cancer treatment in India to patients. Their treatment method involves a combination of two or more of the following methods:
Women are most likely to develop breast cancer and suffer most from this disease. In India, atezolizumab (Tecentriq) was approved as the first immunotherapy drug for triple-negative breast cancer.
Some immunotherapy drugs have shown excellent results in breast cancer clinical trials.
Immunotherapy for cervical cancer
The second most common cancer in women in India is cervical cancer. Infection with HPV (human papillomavirus) is associated with most cervical cancer cases. To prevent cervical cancer, HPV vaccines are given to prevent infection by HPV.
So, book a consultation today with Dr. Saphalta and get the best immunotherapy treatment in Indiaat an affordable price.
The cost of immunotherapy in India varies based on the frequency of the treatment, the drugs used, the overall treatment plan, and the health status of the patient. Consult with your cancer care team about the estimated duration of the treatment and the approximate cost.
Usually, cancer treatment involves a combination of different methods, and the cost may be estimated as a whole. Talking about the estimated cost before starting the treatment would give you a better idea.
Drugs like Nivolumumab, Pembrolizumab, Durvalumab and Atezolizumab are approved and frequently used for immunotherapy treatment in India. These drugs are employed in the treatment of lung cancer, head and neck cancer, liver cancer, kidney cancer, Hodgkin's lymphoma, urinary bladder cancer, and malignant melanoma.
The drug is chosen based on the type and stage of cancer and the patient’s response to it. Consult with your doctor to discuss the type of drug used, its associated benefits, and the potential side effects.
Immunotherapy is generally safe for a large part of the population as a cancer treatment method. However, people with immune system disorders or autoimmune diseases may need to avoid this treatment. Such conditions may include lupus, Crohn’s disease, rheumatoid arthritis, myasthenia gravis, and multiple sclerosis.
Inform your doctor about your current health status and your medical history before devising a treatment plan. This allows them to assess your case and determine your eligibility for different cancer treatment methods.
Immunotherapy has advantages and disadvantages over chemotherapy. While immunotherapy primarily targets and attacks cancerous cells, chemotherapy has a greater risk of causing harm to healthy cells. Consequently, the side effects of immunotherapy are fewer and less severe than those of chemotherapy. However, the effect of chemotherapy is immediate, as it shrinks and kills the tumour cells in a short time, whereas immunotherapy takes longer to show its effect. Therefore, the type and stage of cancer and the patient’s overall health must be taken into consideration before deciding on the primary treatment method in a patient’s cancer treatment plan.
The success rate of immunotherapy in India is estimated to be between 20% and 40%.The individual success rate of immunotherapy for a patient depends on the type and stage of cancer and the person's health status.
Consult with an expert oncologist experienced in immunotherapy treatment to determine if it will be a favorable part of your treatment plan.